Pharmacokinetics, Tissue Distribution, and Toxicology of Tretinoin Incorporated in Liposomes
- 1 January 1994
- journal article
- research article
- Published by Taylor & Francis in Journal of Liposome Research
- Vol. 4 (1) , 689-700
- https://doi.org/10.3109/08982109409037066
Abstract
(1994). Pharmacokinetics, Tissue Distribution, and Toxicology of Tretinoin Incorporated in Liposomes. Journal of Liposome Research: Vol. 4, No. 1, pp. 689-700.Keywords
This publication has 8 references indexed in Scilit:
- Phase I and pharmacokinetic evaluation of all-trans-retinoic acid in pediatric patients with cancer.Journal of Clinical Oncology, 1992
- All-trans-retinoic acid: what is it good for?Journal of Clinical Oncology, 1992
- The "Retinoic Acid Syndrome" in Acute Promyelocytic LeukemiaAnnals of Internal Medicine, 1992
- Continuous treatment with all-trans retinoic acid causes a progressive reduction in plasma drug concentrations: implications for relapse and retinoid "resistance" in patients with acute promyelocytic leukemia [published erratum appears in Blood 1992 Aug 1;80(3):855]Blood, 1992
- Differentiation Therapy of Acute Promyelocytic Leukemia with Tretinoin (All-trans-Retinoic Acid)New England Journal of Medicine, 1991
- All-trans retinoic acid as a differentiation therapy for acute promyelocytic leukemia. I. Clinical results [see comments]Blood, 1990
- Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemiaBlood, 1988
- Treatment of hepatosplenic candidiasis with liposomal-amphotericin B.Journal of Clinical Oncology, 1987